4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-25-020272
President and CEO sold 215,506 shares at an average $3.80 ($818,400)
- President and CEO acquired 332,465 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Patel Sanjiv · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-11 | Sale : show line 1 in the form | −140,182 | $3.85 | $539,701 | 625,948 | D |
| 2025-02-11 | Grant or award : show line 2 in the form | +332,465 | 958,413 | D | ||
| 2025-02-13 | Sale : show line 3 in the form | −75,324 | $3.70 | $278,699 | 883,089 | D |
| Open-market sales · 215,506 sh · avg $3.80 · $818,400 | ||||||
Loading xslF345X05/ownership.xml…